First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Gastric Cancer
In brief
This is a phase 3, multicenter, randomized, double-blind, placebo controlled study of epirubicin, cisplatin \& capecitabine (ECX) with rilotumumab or placebo for untreated advanced MET-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma
Key facts
- Study ID
- NCT01697072
- Run by
- Amgen
- People needed
- 609
- Starts
- 2012-10-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2016-02-09
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Aurora, Colorado, United States
- Research Site — Pueblo, Colorado, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Baltimore, Maryland, United States
- Research Site — Woodbury, Minnesota, United States
- Research Site — Henderson, Nevada, United States
- Research Site — New York, New York, United States
- Research Site — Rochester, New York, United States
- Research Site — Greensboro, North Carolina, United States
- Research Site — Winston-Salem, North Carolina, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Nashville, Tennessee, United States
- Research Site — Bedford, Texas, United States
- Research Site — Dallas, Texas, United States
- Research Site — Seattle, Washington, United States
- Research Site — Randwick, New South Wales, Australia
- Research Site — St Leonards, New South Wales, Australia
- Research Site — Tweed Heads, New South Wales, Australia
- Research Site — Douglas, Queensland, Australia
- Research Site — Elizabeth Vale, South Australia, Australia
- Research Site — Kurralta Park, South Australia, Australia
- Research Site — Heidelberg, Victoria, Australia
- Research Site — Ringwood East, Victoria, Australia
- Research Site — Graz, Austria
- Research Site — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.